Stephen F. Stefano is Director at VALEANT PHARMACEUTICALS INTERNATIONAL (VRX). They have made 5 open-market trades across 1 company since 2009, most recently 2010-09-28.
CIK 0001460463
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $338K since 2009, never a sale. Across 5 scored buys the stock is up 0.4% at ninety days, and 0.2 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| VRX | 19,707 | $461K |
Shares reported on the most recent Form 4, priced at the 2010-07-06 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 100% | 100% |
| Avg Move | -12.8% | +0.4% | +0.4% |
| Alpha | -7.0% | +0.2% | +0.2% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VRX | BUY | 2010-03-01 | 2010-03-02 | $37.28 | $123K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2009-11-04 | 2009-11-04 | $30.82 | $50K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2009-09-04 | 2009-09-08 | $26.03 | $75K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2009-08-10 | 2009-08-11 | $26.64 | $50K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2009-05-12 | 2009-05-13 | $19.78 | $40K | -12.8% | +0.4% | +0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.